Recent studies into retatrutide, a dual agonist for GLP-1 and GIP receptors, are revealing significant results in treating excess mass and related 2 disease. Initial evidence suggest a unique mechanism contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/